ESC 2017 - PACE-CME

Episodes 1-16 of 23

MRA treatment early after STEMI may give mortality benefit
MRA treatment early after STEMI may give mortality benefit
ESC 2017
MRA treatment early after STEMI may give mortality benefit
Imaging components of plaque not more informative than burden of plaque
Imaging components of plaque not more informative than burden of plaque
ESC 2017
Imaging components of plaque not more informative than burden of plaque
- Stephen Nicholls, MD
A new era of CV prevention: Anti-inflammatory drugs on top of lipid lowering
A new era of CV prevention: Anti-inflammatory drugs on top of lipid lowering
ESC 2017
A new era of CV prevention: Anti-inflammatory drugs on top of lipid lowering
Cardiovascular protection in type 2 diabetes
Cardiovascular protection in type 2 diabetes
ESC 2017
Cardiovascular protection in type 2 diabetes
- Prof. Lars Rydén
Novel insights in the management and prognosis of pulmonary hypertension
Novel insights in the management and prognosis of pulmonary hypertension
ESC 2017
Novel insights in the management and prognosis of pulmonary hypertension
- Prof Nazzareno Galiè
Large population study underscores that 'all in moderation' is still good nutrition advice
Large population study underscores that 'all in moderation' is still good nutrition advice
ESC 2017
Large population study underscores that 'all in moderation' is still good nutrition advice
First time CV reduction is achieved with CETP inhibition
First time CV reduction is achieved with CETP inhibition
ESC 2017
First time CV reduction is achieved with CETP inhibition
New therapeutic options can make a difference for diabetic patients with high CV risk
New therapeutic options can make a difference for diabetic patients with high CV risk
ESC 2017
New therapeutic options can make a difference for diabetic patients with high CV risk
- Prof. John E Deanfield, MD
Dopo 23 anni, lo studio CANTOS confermi l'ipotesi sull'infiammazione
Dopo 23 anni, lo studio CANTOS confermi l'ipotesi sull'infiammazione
ESC 2017
Dopo 23 anni, lo studio CANTOS confermi l'ipotesi sull'infiammazione
Take home messages of the ESC congress for better hypertension treatment
Take home messages of the ESC congress for better hypertension treatment
ESC 2017
Take home messages of the ESC congress for better hypertension treatment
- Dr. Clyde Jancy
BP lowering with endovascular baroreflex amplification in resistant hypertension: the CALM-FIM study
BP lowering with endovascular baroreflex amplification in resistant hypertension: the CALM-FIM study
ESC 2017
BP lowering with endovascular baroreflex amplification in resistant hypertension: the CALM-FIM study
- Dr. Wilko Spiering
Well-conducted trial confirms principle that renal denervation can lower blood pressure
Well-conducted trial confirms principle that renal denervation can lower blood pressure
ESC 2017
Well-conducted trial confirms principle that renal denervation can lower blood pressure
Una nueva era para la prevención cardiovascular: anti-inflamatorios además de la reducción lípidica.
Una nueva era para la prevención cardiovascular: anti-inflamatorios además de la reducción lípidica.
ESC 2017
Una nueva era para la prevención cardiovascular: anti-inflamatorios además de la reducción lípidica.
Diverse study data confirm the rationale of intensive lipid-lowering
Diverse study data confirm the rationale of intensive lipid-lowering
ESC 2017
Diverse study data confirm the rationale of intensive lipid-lowering
The journey from vascular biology to the clinic: reducing inflammation lowers CV risk
The journey from vascular biology to the clinic: reducing inflammation lowers CV risk
ESC 2017
The journey from vascular biology to the clinic: reducing inflammation lowers CV risk
LDL-c still reduced after 1 year with siRNA against PCSK9
LDL-c still reduced after 1 year with siRNA against PCSK9
ESC 2017
LDL-c still reduced after 1 year with siRNA against PCSK9

Prev
1
2
Next

1/2